The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Identify scenarios where a sinking fund is more appropriate than a traditional emergency fund, such as planned repairs or purchases, to keep finances organized.
20,708 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Rocket Lab is tightening revenue visibility with a growing backlog and stronger margins entering 2026. Analysts eye h...
Seven U.S. spot XRP ETFs have drawn $1.44B since late 2025, but XRP’s price remains volatile as inflows outpace gains.
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
Bitcoin miners start funding AI pivots by borrowing and selling BTC to stay liquid as margins tighten, hash prices fa...
Netflix announces a second price increase in two years, boosting monthly costs for ad-supported and standard/premium ...
As markets wobble in 2026, retirees face hidden costs from withdrawal sequencing and tax drag that quietly erode life...
AI-powered platforms are cutting construction draw timelines dramatically, compressing review cycles from days to hou...
A small group of under-the-radar stocks is flashing AI-like growth signals while remaining off the radar of most inve...
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...
Apple signals a strategic pivot, moving its flagship away from the iPhone toward ambient computing with Vision Pro an...